These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 25326473

  • 21. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
    Vernon KA, Ruseva MM, Cook HT, Botto M, Malik TH, Pickering MC.
    J Am Soc Nephrol; 2016 May; 27(5):1334-42. PubMed ID: 26374608
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis and treatment of C3 glomerulopathy in a center of expertise.
    Koopman JJE, Teng YKO, Boon CJF, van den Heuvel LP, Rabelink TJ, van Kooten C, de Vries APJ.
    Neth J Med; 2019 Jan; 77(1):10-18. PubMed ID: 30774098
    [Abstract] [Full Text] [Related]

  • 23. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
    Togarsimalemath SK, Sethi SK, Duggal R, Le Quintrec M, Jha P, Daniel R, Gonnet F, Bansal S, Roumenina LT, Fremeaux-Bacchi V, Kher V, Dragon-Durey MA.
    Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
    [Abstract] [Full Text] [Related]

  • 24. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.
    Zhang Y, Keenan A, Dai DF, May KS, Anderson EE, Lindorfer MA, Henrich JB, Pitcher GR, Taylor RP, Smith RJ.
    JCI Insight; 2020 May 07; 5(9):. PubMed ID: 32376801
    [Abstract] [Full Text] [Related]

  • 25. C3 glomerulopathy: a new classification.
    Fakhouri F, Frémeaux-Bacchi V, Noël LH, Cook HT, Pickering MC.
    Nat Rev Nephrol; 2010 Aug 07; 6(8):494-9. PubMed ID: 20606628
    [Abstract] [Full Text] [Related]

  • 26. Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy.
    Barbour TD, Ling GS, Ruseva MM, Fossati-Jimack L, Cook HT, Botto M, Pickering MC.
    Kidney Int; 2016 Apr 07; 89(4):823-32. PubMed ID: 26924054
    [Abstract] [Full Text] [Related]

  • 27. Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.
    Paixão-Cavalcante D, Hanson S, Botto M, Cook HT, Pickering MC.
    Mol Immunol; 2009 Jun 07; 46(10):1942-50. PubMed ID: 19411110
    [Abstract] [Full Text] [Related]

  • 28. Complement activity is regulated in C3 glomerulopathy by IgG-factor H fusion proteins with and without properdin targeting domains.
    Gilmore AC, Zhang Y, Cook HT, Lavin DP, Katti S, Wang Y, Johnson KK, Kim S, Pickering MC.
    Kidney Int; 2021 Feb 07; 99(2):396-404. PubMed ID: 33129896
    [Abstract] [Full Text] [Related]

  • 29. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH, Gitterman DP, Lavin DP, Lomax-Browne HJ, Hiemeyer EC, Moran LB, Boroviak K, Cook HT, Gilmore AC, Mandwie M, Ahmad A, Alexander IE, Logan GJ, Marchbank KJ, Bradley A, Pickering MC.
    Proc Natl Acad Sci U S A; 2021 Mar 30; 118(13):. PubMed ID: 33753502
    [Abstract] [Full Text] [Related]

  • 30. C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.
    Garg N, Zhang Y, Nicholson-Weller A, Khankin EV, Borsa NG, Meyer NC, McDermott S, Stillman IE, Rennke HG, Smith RJ, Pavlakis M.
    Nephrol Dial Transplant; 2018 Dec 01; 33(12):2260-2265. PubMed ID: 29370420
    [Abstract] [Full Text] [Related]

  • 31. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.
    Williams AL, Gullipalli D, Ueda Y, Sato S, Zhou L, Miwa T, Tung KS, Song WC.
    Kidney Int; 2017 Jun 01; 91(6):1386-1397. PubMed ID: 28139294
    [Abstract] [Full Text] [Related]

  • 32. C3 glomerulopathy: consensus report.
    Pickering MC, D'Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT.
    Kidney Int; 2013 Dec 01; 84(6):1079-89. PubMed ID: 24172683
    [Abstract] [Full Text] [Related]

  • 33. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
    Sethi S, Fervenza FC.
    Semin Thromb Hemost; 2014 Jun 01; 40(4):416-21. PubMed ID: 24799306
    [Abstract] [Full Text] [Related]

  • 34. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
    Ruseva MM, Takahashi M, Fujita T, Pickering MC.
    Clin Exp Immunol; 2014 Apr 01; 176(1):84-92. PubMed ID: 24279761
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy.
    Zanchi C, Locatelli M, Cerullo D, Aumiller V, Corna D, Rottoli D, Eisermann M, Donadelli R, Mousavi M, Noris M, Remuzzi G, Benigni A, Zoja C.
    J Immunol; 2022 Apr 01; 208(7):1772-1781. PubMed ID: 35277417
    [Abstract] [Full Text] [Related]

  • 36. Clinicopathological features of C3 glomerulopathy in children: a single-center experience.
    Drake KA, Ellington N, Gattineni J, Torrealba JR, Hendricks AR.
    Pediatr Nephrol; 2020 Jan 01; 35(1):153-162. PubMed ID: 31667615
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy.
    Zanchi C, Locatelli M, Cerullo D, Aumiller V, Corna D, Rottoli D, Schubert S, Noris M, Tomasoni S, Remuzzi G, Zoja C, Benigni A.
    Mol Immunol; 2024 Apr 01; 168():10-16. PubMed ID: 38368725
    [Abstract] [Full Text] [Related]

  • 38. Pathology after eculizumab in dense deposit disease and C3 GN.
    Herlitz LC, Bomback AS, Markowitz GS, Stokes MB, Smith RN, Colvin RB, Appel GB, D'Agati VD.
    J Am Soc Nephrol; 2012 Jul 01; 23(7):1229-37. PubMed ID: 22677550
    [Abstract] [Full Text] [Related]

  • 39. Human factor H-related protein 2 (CFHR2) regulates complement activation.
    Eberhardt HU, Buhlmann D, Hortschansky P, Chen Q, Böhm S, Kemper MJ, Wallich R, Hartmann A, Hallström T, Zipfel PF, Skerka C.
    PLoS One; 2013 Jul 01; 8(11):e78617. PubMed ID: 24260121
    [Abstract] [Full Text] [Related]

  • 40. [Membranoproliferative glomerulonephritis and C3 glomerulopathy].
    Hohenstein B, Amann K, Menne J.
    Internist (Berl); 2019 May 01; 60(5):458-467. PubMed ID: 30859280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.